- Email: [email protected]
Subject Index Volume 51 (2004)
Critical Reviews in Oncology/Hematology 51 (2004) 265
Subject index Volume 51 (2004) Acute respiratory failure 51, 91 Age-differences 51, 69 Aging 51, 249 Breast cancer 51, 55 Cancer diagnosis 51, 249 Cancer 51, 1, 91 Carcinogenesis 51, 1 Chemotherapy 51, 145, 205 Clinical results 51, 81 Colon cancer 51, 121, 145 Differentiation 51, 1 Differentiation therapy 51, 1 Dopamine D2 receptor 51, 191 Drug resistance 51, 205 Drug sensitivity 51, 205 Elderly 51, 229 Embryonal rests 51, 1 Estrogen receptor 51, 55 Function 51, 241 Functional imaging 51, 191 Gastric cancer 51, 105 Gefitinib 51, 29 Gene expression profiling 51, 205 Gene therapy 51, 191 Geriatric assessment 51, 241 Geriatrics 51, 241 Goals 51, 241 Hadrontherapy 51, 81 Health services for the aged 51, 241 Herpes simplex virus type 1 thymidine kinase 51, 191 Information needs 51, 69 Intubation 51, 91 Invasion 51, 55 Ion therapy 51, 81
doi:10.1016/S1040-8428(04)00132-5
Medical decision-making 51, 69 Medical oncology 51, 241 MicroPET 51, 191 Mini-allograft 51, 171 Molecular imaging 51, 191 NCI60 panel 51, 205 Neutropenia 51, 91 New biological agents 51, 29 New targeted therapies 51, 45 Non-Hodkgin’s lymphoma 51, 229 Non-invasive ventilation 51, 91 Non-small cell lung cancer 51, 29 Nonmyeloablative 51, 171 Older cancer survivors 51, 249 Outcomes 51, 241 Patients’ preferences 51, 69 PET 51, 191 Plasticity 51, 1 Pulmonary infections 51, 91 Quality assurance 51, 105 Quality of life 51, 69 Radiotherapy 51, 81 Rectal cancer 51, 105, 121 Reduced intensity conditioning 51, 171 Reporter gene 51, 191 Retinoic acid 51, 1 Small-cell lung cancer 51, 45 Stem cells 51, 1 Surgery 51, 105 Symptoms 51, 241 Targeted therapy 51, 29 Therapy 51, 55 Tumour 51, 81, 121, 145
Subject index Volume 51 (2004) Acute respiratory failure 51, 91 Age-differences 51, 69 Aging 51, 249 Breast cancer 51, 55 Cancer diagnosis 51, 249 Cancer 51, 1, 91 Carcinogenesis 51, 1 Chemotherapy 51, 145, 205 Clinical results 51, 81 Colon cancer 51, 121, 145 Differentiation 51, 1 Differentiation therapy 51, 1 Dopamine D2 receptor 51, 191 Drug resistance 51, 205 Drug sensitivity 51, 205 Elderly 51, 229 Embryonal rests 51, 1 Estrogen receptor 51, 55 Function 51, 241 Functional imaging 51, 191 Gastric cancer 51, 105 Gefitinib 51, 29 Gene expression profiling 51, 205 Gene therapy 51, 191 Geriatric assessment 51, 241 Geriatrics 51, 241 Goals 51, 241 Hadrontherapy 51, 81 Health services for the aged 51, 241 Herpes simplex virus type 1 thymidine kinase 51, 191 Information needs 51, 69 Intubation 51, 91 Invasion 51, 55 Ion therapy 51, 81
doi:10.1016/S1040-8428(04)00132-5
Medical decision-making 51, 69 Medical oncology 51, 241 MicroPET 51, 191 Mini-allograft 51, 171 Molecular imaging 51, 191 NCI60 panel 51, 205 Neutropenia 51, 91 New biological agents 51, 29 New targeted therapies 51, 45 Non-Hodkgin’s lymphoma 51, 229 Non-invasive ventilation 51, 91 Non-small cell lung cancer 51, 29 Nonmyeloablative 51, 171 Older cancer survivors 51, 249 Outcomes 51, 241 Patients’ preferences 51, 69 PET 51, 191 Plasticity 51, 1 Pulmonary infections 51, 91 Quality assurance 51, 105 Quality of life 51, 69 Radiotherapy 51, 81 Rectal cancer 51, 105, 121 Reduced intensity conditioning 51, 171 Reporter gene 51, 191 Retinoic acid 51, 1 Small-cell lung cancer 51, 45 Stem cells 51, 1 Surgery 51, 105 Symptoms 51, 241 Targeted therapy 51, 29 Therapy 51, 55 Tumour 51, 81, 121, 145